Summary

Nucleic Acid Aptamers Market – Scope of Report
TMR’s report on the global nucleic acid aptamers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global nucleic acid aptamers market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nucleic acid aptamers market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the nucleic acid aptamers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nucleic acid aptamers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nucleic acid aptamers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nucleic acid aptamers market.

The report delves into the competitive landscape of the global nucleic acid aptamers market. Key players operating in the global nucleic acid aptamers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nucleic acid aptamers market profiled in this report.

Key Questions Answered in Global nucleic acid aptamers Market Report
• What is the sales/revenue generated by nucleic acid aptamers across all regions during the forecast period?
• What are the opportunities in the global nucleic acid aptamers market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Nucleic Acid Aptamers Market – Research Objectives and Research Approach
The comprehensive report on the global nucleic acid aptamers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nucleic acid aptamers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nucleic acid aptamers market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nucleic Acid Aptamers Market
4. Market Overview
    4.1. Introduction
        4.1.1. Type Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Nucleic Acid Aptamers Market Analysis and Forecasts, 2020-2034
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Technological Advancements
    5.2. PORTERs Five Forces Analysis
    5.3. Value Chain Analysis
6. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Type, 2020-2034
        6.3.1. DNA Aptamer
        6.3.2. RNA Aptamer
        6.3.3. XNA Aptamer
    6.4. Market Attractiveness By Type
7. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Application, 2020-2034
        7.3.1. Drug Delivery
        7.3.2. Anti-viral Therapy
        7.3.3. Pathogen Recognition
        7.3.4. Disease Recognition
        7.3.5. Stem Cell Markers
        7.3.6. Others
    7.4. Market Attractiveness By Application
8. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Indication
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By Indication, 2020-2034
        8.3.1. Viral infection
        8.3.2. Cancer
        8.3.3. Ophthalmology
        8.3.4. Others
    8.4. Market Attractiveness By Indication
9. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By End-user
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast By End-user, 2020-2034
        9.3.1. Biopharmaceutical Companies
        9.3.2. Diagnostic Centers
        9.3.3. CROs
        9.3.4. Others
    9.4. Market Attractiveness By End-user
10. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Region
    10.1. Key Findings
    10.2. Market Value Forecast By Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness By Country/Region
11. North America Nucleic Acid Aptamers Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Type, 2020-2034
        11.2.1. DNA Aptamer
        11.2.2. RNA Aptamer
        11.2.3. XNA Aptamer
    11.3. Market Value Forecast By Application, 2020-2034
        11.3.1. Drug-Delivery
        11.3.2. Anti-viral Therapy
        11.3.3. Pathogen Recognition
        11.3.4. Disease Recognition
        11.3.5. Stem Cell Markers
        11.3.6. Others
    11.4. Market Value Forecast By Indication, 2020-2034
        11.4.1. Viral infection
        11.4.2. Cancer
        11.4.3. Ophthalmology
        11.4.4. Others
    11.5. Market Value Forecast By End-user, 2020-2034
        11.5.1. Biopharmaceutical Companies
        11.5.2. Diagnostic Centers
        11.5.3. CROs
        11.5.4. Others
    11.6. Market Value Forecast By Country, 2020-2034
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Type
        11.7.2. By Application
        11.7.3. By Indication
        11.7.4. By End-user
        11.7.5. By Country
12. Europe Nucleic Acid Aptamers Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Type, 2020-2034
        12.2.1. DNA Aptamer
        12.2.2. RNA Aptamer
        12.2.3. XNA Aptamer
    12.3. Market Value Forecast By Application, 2020-2034
        12.3.1. Drug-Delivery
        12.3.2. Anti-viral Therapy
        12.3.3. Pathogen Recognition
        12.3.4. Disease Recognition
        12.3.5. Stem Cell Markers
        12.3.6. Others
    12.4. Market Value Forecast By Indication, 2020-2034
        12.4.1. Viral infection
        12.4.2. Cancer
        12.4.3. Ophthalmology
        12.4.4. Others
    12.5. Market Value Forecast By End-user, 2020-2034
        12.5.1. Biopharmaceutical Companies
        12.5.2. Diagnostic Centers
        12.5.3. CROs
        12.5.4. Others
    12.6. Market Value Forecast By Country/Sub-region, 2020-2034
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Type
        12.7.2. By Application
        12.7.3. By Indication
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific Nucleic Acid Aptamers Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Type, 2020-2034
        13.2.1. DNA Aptamer
        13.2.2. RNA Aptamer
        13.2.3. XNA Aptamer
    13.3. Market Value Forecast By Application, 2020-2034
        13.3.1. Drug-Delivery
        13.3.2. Anti-viral Therapy
        13.3.3. Pathogen Recognition
        13.3.4. Disease Recognition
        13.3.5. Stem Cell Markers
        13.3.6. Others
    13.4. Market Value Forecast By Indication, 2020-2034
        13.4.1. Viral infection
        13.4.2. Cancer
        13.4.3. Ophthalmology
        13.4.4. Others
    13.5. Market Value Forecast By End-user, 2020-2034
        13.5.1. Biopharmaceutical Companies
        13.5.2. Diagnostic Centers
        13.5.3. CROs
        13.5.4. Others
    13.6. Market Value Forecast By Country/Sub-region, 2020-2034
        13.6.1. China
        13.6.2. India
        13.6.3. Japan
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Type
        13.7.2. By Application
        13.7.3. By Indication
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America Nucleic Acid Aptamers Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Type, 2020-2034
        14.2.1. DNA Aptamer
        14.2.2. RNA Aptamer
        14.2.3. XNA Aptamer
    14.3. Market Value Forecast By Application, 2020-2034
        14.3.1. Drug-Delivery
        14.3.2. Anti-viral Therapy
        14.3.3. Pathogen Recognition
        14.3.4. Disease Recognition
        14.3.5. Stem Cell Markers
        14.3.6. Others
    14.4. Market Value Forecast By Indication, 2020-2034
        14.4.1. Viral infection
        14.4.2. Cancer
        14.4.3. Ophthalmology
        14.4.4. Others
    14.5. Market Value Forecast By End-user, 2020-2034
        14.5.1. Biopharmaceutical Companies
        14.5.2. Diagnostic Centers
        14.5.3. CROs
        14.5.4. Others
    14.6. Market Value Forecast By Country/Sub-region, 2020-2034
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Type
        14.7.2. By Application
        14.7.3. By Indication
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa Nucleic Acid Aptamers Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast By Type, 2020-2034
        15.2.1. DNA Aptamer
        15.2.2. RNA Aptamer
        15.2.3. XNA Aptamer
    15.3. Market Value Forecast By Application, 2020-2034
        15.3.1. Drug-Delivery
        15.3.2. Anti-viral Therapy
        15.3.3. Pathogen Recognition
        15.3.4. Disease Recognition
        15.3.5. Stem Cell Markers
        15.3.6. Others
    15.4. Market Value Forecast By Indication, 2020-2034
        15.4.1. Viral infection
        15.4.2. Cancer
        15.4.3. Ophthalmology
        15.4.4. Others
    15.5. Market Value Forecast By End-user, 2020-2034
        15.5.1. Biopharmaceutical Companies
        15.5.2. Diagnostic Centers
        15.5.3. CROs
        15.5.4. Others
    15.6. Market Value Forecast By Country/Sub-region, 2020-2034
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Type
        15.7.2. By Application
        15.7.3. By Indication
        15.7.4. By End-user
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player - Competition Matrix (By Tier and Size of companies)
    16.2. Company Profiles
        16.2.1. Aptagen Labs
            16.2.1.1. Company Overview
            16.2.1.2. Financial Overview
            16.2.1.3. Product Portfolio
            16.2.1.4. Business Strategies
            16.2.1.5. Recent Developments
        16.2.2. Aptamer Group
            16.2.2.1. Company Overview
            16.2.2.2. Financial Overview
            16.2.2.3. Product Portfolio
            16.2.2.4. Business Strategies
            16.2.2.5. Recent Developments
        16.2.3. Base Pair Biotechnologies
            16.2.3.1. Company Overview
            16.2.3.2. Financial Overview
            16.2.3.3. Product Portfolio
            16.2.3.4. Business Strategies
            16.2.3.5. Recent Developments
        16.2.4. NeoVentures Biotechnology Inc.
            16.2.4.1. Company Overview
            16.2.4.2. Financial Overview
            16.2.4.3. Product Portfolio
            16.2.4.4. Business Strategies
            16.2.4.5. Recent Developments
        16.2.5. Aptamer Sciences, Inc.
            16.2.5.1. Company Overview
            16.2.5.2. Financial Overview
            16.2.5.3. Product Portfolio
            16.2.5.4. Business Strategies
            16.2.5.5. Recent Developments
        16.2.6. SomaLogic Operating Co., Inc.
            16.2.6.1. Company Overview
            16.2.6.2. Financial Overview
            16.2.6.3. Product Portfolio
            16.2.6.4. Business Strategies
            16.2.6.5. Recent Developments
        16.2.7. AptaTargets SL.
            16.2.7.1. Company Overview
            16.2.7.2. Financial Overview
            16.2.7.3. Product Portfolio
            16.2.7.4. Business Strategies
            16.2.7.5. Recent Developments
        16.2.8. Aptus Biotech S.L.
            16.2.8.1. Company Overview
            16.2.8.2. Financial Overview
            16.2.8.3. Product Portfolio
            16.2.8.4. Business Strategies
            16.2.8.5. Recent Developments
        16.2.9. Other Prominent Players
            16.2.9.1. Company Overview
            16.2.9.2. Financial Overview
            16.2.9.3. Product Portfolio
            16.2.9.4. Business Strategies
            16.2.9.5. Recent Developments